Citable filing context
DOC's research view summarizes recent SEC filing context, starting with earnings from Aug 4, 2026.
| Filed | Item | Context |
|---|---|---|
| Aug 4, 2026 | earnings | Healthpeak Properties reported second quarter 2026 financial results and increased its full-year 2026 earnings guidance. |
| May 4, 2026 | other | Healthpeak Properties, Inc. reported that stockholders approved all proposals at its annual meeting on April 30, 2026. |
| Mar 23, 2026 | debt_offering | Healthpeak amended credit agreements to establish a $400 million DDTL facility and increase borrowing capacity to $2.0 billion. |
| Aug 4, 2026 | Guidance: diluted_eps | 0.48 to 0.52 |
| Aug 4, 2026 | Guidance: diluted_ffo_as_adjusted_per_share | 1.73 to 1.77 |
| Aug 4, 2026 | Guidance: total_same_store_cash_adjusted_noi | 0.00 to 1.50 |
| Aug 5, 2026 | mda_quarterly | Healthpeak Properties (DOC) operates as a diversified REIT focused on healthcare discovery and delivery, with a portfolio spanning outpatient medical, lab, and senior housing segments. A significant strategic development in 2026 was the initial public offering of Janus Living, a pure-play senior housing REIT. Healthpeak retains a 73.6% voting and economic interest in Janus Living, which is now consolidated in Healthpeak’s financial statements. Financially, the company is managing a transition in its senior housing portfolio, highlighted by the $312 million SWF JV Buyout in January 2026, which consolidated 19 senior housing communities. The company also executed a major portfolio optimization in July 2026 by forming a joint venture with Brookfield Asset Management, contributing 86 outpatient medical buildings at a $2.1 billion valuation and generating $1.025 billion in proceeds. Liquidity remains a priority, supported by a $3.0 billion revolving credit facility and a $2.0 billion commercial paper program. As of June 30, 2026, the company held $1.6 billion in cash and cash equivalents. Key risks identified include macroeconomic volatility, interest rate fluctuations affecting borrowing costs, and the regulatory and funding uncertainties inherent in the life science and healthcare sectors. The company continues to utilize share repurchases, having authorized a new $500 million program in July 2026. |
| May 6, 2026 | mda_quarterly | Healthpeak Properties focuses on outpatient medical, lab, and senior housing real estate. A pivotal development in March 2026 was the Janus Living IPO, which generated $966 million in gross proceeds; Healthpeak retains 81.6% ownership and continues to consolidate the entity. During the first quarter of 2026, the company expanded its senior housing portfolio through the $312 million SWF JV buyout and acquisitions in Atlanta, Orlando, and Seattle. Conversely, it reduced its outpatient medical footprint by selling an 80% interest in six buildings for $163 million. Net income attributable to common shares rose to $193.5 million, bolstered by gains on change of control and real estate sales, although Nareit FFO decreased slightly. Segment performance was mixed: senior housing Same-Store Adjusted NOI grew 13.8% on higher resident fees and occupancy, and outpatient medical grew 2.4%, while lab Same-Store Adjusted NOI declined 7.2% due to lower occupancy and higher operating expenses. Total debt increased to $10.4 billion, primarily via the commercial paper program. Key risks include interest rate volatility, inflation, and funding uncertainty within the life sciences industry, which specifically pressures the lab segment. |
Source: SEC EDGAR filing text and events; period Aug 4, 2026; filed Aug 4, 2026.
DOC company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.